Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2012; 18(10): 1085-1092
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1085
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1085
Table 1 Overview of the quality framework presenting definitions, purposes, data sources and operational definitions for the adopted quality measures as well as properties of the applied models
Characteristics of measures included in the framework | Properties of the models included in the framework | ||||||
Quality measure | Definition of measure | Data source and data collection | Operational definition of measure | Purposes for the measure adapted from Behn | Quality dimensionaccording to the clinical value compass | Quality components as part of the quality model of Donabedian | |
Patient data | Diagnosis | Inflammatory bowel disease | Local gastro registry | Crohn’s disease and ulcerative colitis | Control, evaluation | Clinical dimension | Outcome |
Gender | Sex | Local gastro registry | female:male | Control, learning | Clinical dimension | Structure | |
Age | Local gastro registry | Age [mean (SD)] range | Control, learning | Clinical dimension | Structure | ||
Disease duration | Début year | Local gastro registry | Years since time of diagnosis [mean (SD)] range | Control, evaluation | Clinical dimension | Outcome | |
Laboratory measures | Hemoglobin | Blood sample enabling detection of anemia associated with chronic disease, blood loss, or iron deficiency | Local gastro registry Tests were performed at the nearest primary care center and reported electronically | Cut-off points were defined as: mean (SD) normal ≥ 120 g/L, anemia 100-119 g/L severe anemia < 100 g/L missing | Control, evaluation | Clinical dimension | Outcome |
Medication | Prescribed medicine | Currently prescribed preventive medication | Local gastro registry | Prescribed medication: 5-ASA cortisone immunosuppressive anti-TNF-α no medication | Control, evaluation | Clinical dimension | Process |
Surgical interventions | Incidence of surgery | Surgical interventions associated with IBD | ERS, searched for ICD codes for surgical interventions and IBD once a year | Type and numbers of surgical interventions: colectomy hemicolectomy loop ileostomy perianal/fistula/ stricture incision revision abdominal scar | Evaluation | Clinical and cost dimension | Process |
Tumor incidence | Incidence of gastrointestinal tumors associated with IBD | Data from the national tumor registry retrieved once a year | Number and type of intestinal tumors associated with IBD according to diagnosis in records as ICD code | Evaluation | Clinical and cost dimension | Outcome | |
Quality of life | The Short Health Scale, SHS | SHS is a health related quality of life questionnaire consisting of four questions graded on a 6 point Likert scale. | Local gastro registry | Percent scoring 1 to 3 representing that the goal of the care was reached symptoms functioning worry wellbeing | Evaluation | Functional dimension | Outcome |
Access to care | Waiting time | Referral from primary to secondary care | Local administrative data base | Number of days from the referral being sent from the primary care physician until the patient received a scheduled consultation at the outpatient clinic | Motivation, budget, learning, evaluation, promotion | A proxy for the satisfaction dimension | Process and outcome |
Waiting time for known patients | An acute visit is used for an urgent need of assessment due to deteriorating disease | Local administrative data base | The clinic’s ability to offer an acute visit within two days after contact for known IBD patients | Motivation, budget, learning, evaluation, promote | A proxy for the satisfaction dimension | Process | |
Contact route (before being admitted to hospital) | The place for the decision to admit the patient for inpatient care, i.e. either at the ER or the outpatient clinic | ERS Contact route was decided after finding indicators such as: where the note was written, if the note was written by an on call colleague or a gastroenterologist | The ERS was searched to find out where the decision was either at the ER or from the outpatient clinic | Learning | Cost and a proxy for the satisfaction dimension | Process | |
Hospitalization | Hospitalization | Individual and total numbers of admittances for IBD patients | ERS was searched for ICD codes and national data was retrieved from the National Board of Health and Welfare | ERS documented ICD code for IBD and hospitalisation | Motivation, budget, evaluation | Cost dimension | Process and outcome |
Table 2 Quality framework applied to the inflammatory bowel disease care setting at the Department of Internal Medicine in Highland Hospital, Eksjö, Jönköping County, Sweden
Quality measures from 2008 | Crohn’s disease | Ulcerative colitis | |
Patient data | Diagnosis | 194 | 261 |
Gender | |||
Female:male | 44%:56% | 42%:58% | |
Age (yr) | |||
Mean (SD) | 53 (± 15) | 51 (± 15) | |
Range | 18-90 | 20-91 | |
Disease duration | |||
Years since time of diagnosis | |||
Mean (SD) | 20 (± 13) | 14 (± 10)) | |
Range | 0-58 | 0-53 | |
Laboratory measures | Hemoglobin | ||
Mean (SD) | 140 (± 12) | 143 (± 13) | |
Normal ≥ 120 g/L | 95% | 96% | |
Anemia 100-119 g/L | 4% | 4% | |
Severe anemia < 100 g/L | < 1% | 0 | |
Missing | 16% | 17% | |
Medication | Prescribed medicine | ||
5-ASA | 43% | 56% | |
Cortisone | 16% | 4% | |
Immunosuppressant | 34% | 12% | |
Anti-TNF-α | 8% | 2% | |
No medication | 31% | 40% | |
Surgical | Incidence of surgery | ||
interventions | Type and numbers of surgical interventions: | ||
Colonectomy | 3 | ||
Hemicolectomy | 1 | 1 | |
Loop ileostomy | 1 | ||
Perianal/fistula/stricture incision | 3 | 1 | |
Revision abdominal scar | 1 | ||
Tumor incidence | |||
Number and type of intestinal tumors associated with IBD according to diagnosis in records as ICD code | 0 | 0 | |
Quality of life | The Short Health Scale, SHS | ||
Percent scoring 1 to 3 representing that the goal of the care was reached | |||
symptoms | 95% | 98% | |
functioning | 88% | 95% | |
worry | 91% | 94% | |
wellbeing | 97% | 96% | |
Access to care | Waiting time | ||
Number of days from the referral being sent from the primary care physician until the patient received a scheduled consultation at the outpatient clinic | < 3 wk | < 3 wk | |
Waiting time for known patients | |||
The clinic’s ability to offer an acute visit within two days after contact for known IBD patients | < 2 d | < 2 d | |
Contact route (before being admitted to hospital) | |||
The ERS was searched to find out where the decision was either at the ER or from the outpatient clinic | 50%/50% | 50%/50% | |
Hospitalization | Hospitalization | ||
ERS documented ICD code for IBD and hospitalisation | 29 | 17 |
- Citation: Rejler M, Tholstrup J, Elg M, Spångéus A, Gäre BA. Framework for assessing quality of care for inflammatory bowel disease in Sweden. World J Gastroenterol 2012; 18(10): 1085-1092
- URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1085.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i10.1085